Skip to main content
XLO logo

XLO · Xilio Therapeutics, Inc.

$9.10 -0.05 (-0.55%) At close · Jul 29
Market Cap
$52.62M
Shares
5.78M

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-07-29 2,567 0 3,709 69.2%
2026-07-28 13,176 0 22,320 59.0%
2026-07-27 15,382 0 22,052 69.8%
2026-07-24 4,757 10 6,816 69.8%
2026-07-23 17,235 0 20,825 82.8%
2026-07-22 5,486 0 11,313 48.5%
2026-07-21 6,573 0 8,574 76.7%
2026-07-20 8,907 0 13,072 68.1%
2026-07-17 12,731 0 23,308 54.6%
2026-07-16 23,394 0 34,624 67.6%
2026-07-15 36,178 0 37,850 95.6%
2026-07-14 53,020 0 56,311 94.2%
2026-07-13 21,551 0 25,513 84.5%
2026-07-10 669 0 2,176 30.7%
2026-07-09 3,075 0 4,417 69.6%
2026-07-08 1,917 0 4,453 43.0%
2026-07-07 1,046 0 3,377 31.0%
2026-07-06 829 0 3,255 25.5%
2026-07-02 472 0 6,690 7.1%
2026-07-01 3,011 0 5,137 58.6%
2026-06-30 3,875 50 8,355 46.4%
2026-06-29 7,447 0 38,139 19.5%
2026-06-26 4,435 0 14,983 29.6%
2026-06-25 2,778 0 4,243 65.5%
2026-06-24 2,640 100 10,246 25.8%
2026-06-23 4,292 0 11,576 37.1%
2026-06-22 2,099 280 8,324 25.2%
2026-06-18 2,257 169 23,490 9.6%
2026-06-17 5,717 17 55,064 10.4%
2026-06-16 1,784 0 7,418 24.0%
2026-06-15 4,335 0 29,825 14.5%
2026-06-12 3,448 0 7,223 47.7%
2026-06-11 920 0 3,167 29.0%
2026-06-10 1,403 0 6,813 20.6%
2026-06-09 11,501 0 21,177 54.3%
2026-06-08 5,262 31 14,664 35.9%
2026-06-05 11,496 0 27,002 42.6%
2026-06-04 2,178 0 3,654 59.6%
2026-06-03 658 0 3,233 20.4%
2026-06-02 5,783 0 13,944 41.5%
2026-06-01 4,763 0 10,680 44.6%
2026-05-29 3,574 0 9,438 37.9%
2026-05-28 2,270 0 16,157 14.0%
2026-05-27 4,262 0 12,249 34.8%
2026-05-26 1,010 0 15,466 6.5%
2026-05-22 9,241 0 20,705 44.6%
2026-05-21 1,111 0 3,113 35.7%
2026-05-20 3,282 0 8,535 38.5%
2026-05-19 4,055 0 11,023 36.8%
2026-05-18 4,680 0 18,045 25.9%
Showing 1–50 of 62 days
Key facts CIK 1840233 CUSIP 98422T209 13F (30d) 1 filings 1 filers Visit website Investor relations